Table 1.
Feature | |
---|---|
Age of patients (years, median) | 64.12 |
Preoperative serum PSA (ng/mL, median) | 8.50 |
Tumor size (cm, median) | 2.25 |
Pathologic stage (%) | |
pT2 | 74.00 |
pT3 | 26.00 |
Gleason score (%) | |
≤6 | 65.40 |
≥7 | 34.60 |
Margin status (%) | |
Positive | 58.82 |
Negative | 41.17 |
Disease-free survival (months) | |
Negative margin group | 31.2 |
Positive margin group | 22.6 |